Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segments

1.4.1. Market size breakdown, by offering

1.4.2. Market size breakdown, by allergen

1.4.3. Market size breakdown, by test type

1.4.4. Market size breakdown, by end user

1.4.5. Market size breakdown, by region

1.4.6. Market size breakdown, by country

1.5. Market Data Reporting Unit

1.5.1. Volume

1.5.2. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Market Dynamics

5.1.1. Trends

5.1.2. Drivers

5.1.3. Restraints/challenges

5.1.4. Impact analysis of drivers/restraints

5.2. Impact of COVID-19

5.3. Porter’s Five Forces Analysis

5.3.1. Bargaining power of buyers

5.3.2. Bargaining power of suppliers

5.3.3. Threat of new entrants

5.3.4. Intensity of rivalry

5.3.5. Threat of substitutes

Chapter 6. Global Market

6.1. Overview

6.2. Market Volume, by Offering (2017–2030)

6.2.1. Instruments market volume, by type (2017–2030)

6.3. Market Revenue, by Offering (2017–2030)

6.3.1. Instruments market revenue, by type (2017–2030)

6.4. Market Volume, by Allergen (2017–2030)

6.5. Market Revenue, by Allergen (2017–2030)

6.6. Market Volume, by Test Type (2017–2030)

6.7. Market Revenue, by Test Type (2017–2030)

6.8. Market Volume, by End User (2017–2030)

6.9. Market Revenue, by End User (2017–2030)

6.10. Market Volume, by Region (2017–2030)

6.11. Market Revenue, by Region (2017–2030)

Chapter 7. North America Market

7.1. Overview

7.2. Market Volume, by Offering (2017–2030)

7.2.1. Instruments market volume, by type (2017–2030)

7.3. Market Revenue, by Offering (2017–2030)

7.3.1. Instruments market revenue, by type (2017–2030)

7.4. Market Volume, by Allergen (2017–2030)

7.5. Market Revenue, by Allergen (2017–2030)

7.6. Market Volume, by Test Type (2017–2030)

7.7. Market Revenue, by Test Type (2017–2030)

7.8. Market Volume, by End User (2017–2030)

7.9. Market Revenue, by End User (2017–2030)

7.10. Market Volume, by Country (2017–2030)

7.11. Market Revenue, by Country (2017–2030)

Chapter 8. Europe Market

8.1. Overview

8.2. Market Volume, by Offering (2017–2030)

8.2.1. Instruments market volume, by type (2017–2030)

8.3. Market Revenue, by Offering (2017–2030)

8.3.1. Instruments market revenue, by type (2017–2030)

8.4. Market Volume, by Allergen (2017–2030)

8.5. Market Revenue, by Allergen (2017–2030)

8.6. Market Volume, by Test Type (2017–2030)

8.7. Market Revenue, by Test Type (2017–2030)

8.8. Market Volume, by End User (2017–2030)

8.9. Market Revenue, by End User (2017–2030)

8.10. Market Volume, by Country (2017–2030)

8.11. Market Revenue, by Country (2017–2030)

Chapter 9. APAC Market

9.1. Overview

9.2. Market Volume, by Offering (2017–2030)

9.2.1. Instruments market volume, by type (2017–2030)

9.3. Market Revenue, by Offering (2017–2030)

9.3.1. Instruments market revenue, by type (2017–2030)

9.4. Market Volume, by Allergen (2017–2030)

9.5. Market Revenue, by Allergen (2017–2030)

9.6. Market Volume, by Test Type (2017–2030)

9.7. Market Revenue, by Test Type (2017–2030)

9.8. Market Volume, by End User (2017–2030)

9.9. Market Revenue, by End User (2017–2030)

9.10. Market Volume, by Country (2017–2030)

9.11. Market Revenue, by Country (2017–2030)

Chapter 10. LATAM Market

10.1. Overview

10.2. Market Volume, by Offering (2017–2030)

10.2.1. Instruments market volume, by type (2017–2030)

10.3. Market Revenue, by Offering (2017–2030)

10.3.1. Instruments market revenue, by type (2017–2030)

10.4. Market Volume, by Allergen (2017–2030)

10.5. Market Revenue, by Allergen (2017–2030)

10.6. Market Volume, by Test Type (2017–2030)

10.7. Market Revenue, by Test Type (2017–2030)

10.8. Market Volume, by End User (2017–2030)

10.9. Market Revenue, by End User (2017–2030)

10.10. Market Volume, by Country (2017–2030)

10.11. Market Revenue, by Country (2017–2030)

Chapter 11. MEA Market

11.1. Overview

11.2. Market Volume, by Offering (2017–2030)

11.2.1. Instruments market volume, by type (2017–2030)

11.3. Market Revenue, by Offering (2017–2030)

11.3.1. Instruments market revenue, by type (2017–2030)

11.4. Market Volume, by Allergen (2017–2030)

11.5. Market Revenue, by Allergen (2017–2030)

11.6. Market Volume, by Test Type (2017–2030)

11.7. Market Revenue, by Test Type (2017–2030)

11.8. Market Volume, by End User (2017–2030)

11.9. Market Revenue, by End User (2017–2030)

11.10. Market Volume, by Country (2017–2030)

11.11. Market Revenue, by Country (2017–2030)

Chapter 12. U.S. Market

12.1. Overview

12.2. Market Volume, by Offering (2017–2030)

12.2.1. Instruments market volume, by type (2017–2030)

12.3. Market Revenue, by Offering (2017–2030)

12.3.1. Instruments market revenue, by type (2017–2030)

12.4. Market Volume, by Allergen (2017–2030)

12.5. Market Revenue, by Allergen (2017–2030)

12.6. Market Volume, by Test Type (2017–2030)

12.7. Market Revenue, by Test Type (2017–2030)

12.8. Market Volume, by End User (2017–2030)

12.9. Market Revenue, by End User (2017–2030)

Chapter 13. Canada Market

13.1. Overview

13.2. Market Volume, by Offering (2017–2030)

13.2.1. Instruments market volume, by type (2017–2030)

13.3. Market Revenue, by Offering (2017–2030)

13.3.1. Instruments market revenue, by type (2017–2030)

13.4. Market Volume, by Allergen (2017–2030)

13.5. Market Revenue, by Allergen (2017–2030)

13.6. Market Volume, by Test Type (2017–2030)

13.7. Market Revenue, by Test Type (2017–2030)

13.8. Market Volume, by End User (2017–2030)

13.9. Market Revenue, by End User (2017–2030)

Chapter 14. Germany Market

14.1. Overview

14.2. Market Volume, by Offering (2017–2030)

14.2.1. Instruments market volume, by type (2017–2030)

14.3. Market Revenue, by Offering (2017–2030)

14.3.1. Instruments market revenue, by type (2017–2030)

14.4. Market Volume, by Allergen (2017–2030)

14.5. Market Revenue, by Allergen (2017–2030)

14.6. Market Volume, by Test Type (2017–2030)

14.7. Market Revenue, by Test Type (2017–2030)

14.8. Market Volume, by End User (2017–2030)

14.9. Market Revenue, by End User (2017–2030)

Chapter 15. France Market

15.1. Overview

15.2. Market Volume, by Offering (2017–2030)

15.2.1. Instruments market volume, by type (2017–2030)

15.3. Market Revenue, by Offering (2017–2030)

15.3.1. Instruments market revenue, by type (2017–2030)

15.4. Market Volume, by Allergen (2017–2030)

15.5. Market Revenue, by Allergen (2017–2030)

15.6. Market Volume, by Test Type (2017–2030)

15.7. Market Revenue, by Test Type (2017–2030)

15.8. Market Volume, by End User (2017–2030)

15.9. Market Revenue, by End User (2017–2030)

Chapter 16. U.K. Market

16.1. Overview

16.2. Market Volume, by Offering (2017–2030)

16.2.1. Instruments market volume, by type (2017–2030)

16.3. Market Revenue, by Offering (2017–2030)

16.3.1. Instruments market revenue, by type (2017–2030)

16.4. Market Volume, by Allergen (2017–2030)

16.5. Market Revenue, by Allergen (2017–2030)

16.6. Market Volume, by Test Type (2017–2030)

16.7. Market Revenue, by Test Type (2017–2030)

16.8. Market Volume, by End User (2017–2030)

16.9. Market Revenue, by End User (2017–2030)

Chapter 17. Italy Market

17.1. Overview

17.2. Market Volume, by Offering (2017–2030)

17.2.1. Instruments market volume, by type (2017–2030)

17.3. Market Revenue, by Offering (2017–2030)

17.3.1. Instruments market revenue, by type (2017–2030)

17.4. Market Volume, by Allergen (2017–2030)

17.5. Market Revenue, by Allergen (2017–2030)

17.6. Market Volume, by Test Type (2017–2030)

17.7. Market Revenue, by Test Type (2017–2030)

17.8. Market Volume, by End User (2017–2030)

17.9. Market Revenue, by End User (2017–2030)

Chapter 18. Spain Market

18.1. Overview

18.2. Market Volume, by Offering (2017–2030)

18.2.1. Instruments market volume, by type (2017–2030)

18.3. Market Revenue, by Offering (2017–2030)

18.3.1. Instruments market revenue, by type (2017–2030)

18.4. Market Volume, by Allergen (2017–2030)

18.5. Market Revenue, by Allergen (2017–2030)

18.6. Market Volume, by Test Type (2017–2030)

18.7. Market Revenue, by Test Type (2017–2030)

18.8. Market Volume, by End User (2017–2030)

18.9. Market Revenue, by End User (2017–2030)

Chapter 19. Japan Market

19.1. Overview

19.2. Market Volume, by Offering (2017–2030)

19.2.1. Instruments market volume, by type (2017–2030)

19.3. Market Revenue, by Offering (2017–2030)

19.3.1. Instruments market revenue, by type (2017–2030)

19.4. Market Volume, by Allergen (2017–2030)

19.5. Market Revenue, by Allergen (2017–2030)

19.6. Market Volume, by Test Type (2017–2030)

19.7. Market Revenue, by Test Type (2017–2030)

19.8. Market Volume, by End User (2017–2030)

19.9. Market Revenue, by End User (2017–2030)

Chapter 20. China Market

20.1. Overview

20.2. Market Volume, by Offering (2017–2030)

20.2.1. Instruments market volume, by type (2017–2030)

20.3. Market Revenue, by Offering (2017–2030)

20.3.1. Instruments market revenue, by type (2017–2030)

20.4. Market Volume, by Allergen (2017–2030)

20.5. Market Revenue, by Allergen (2017–2030)

20.6. Market Volume, by Test Type (2017–2030)

20.7. Market Revenue, by Test Type (2017–2030)

20.8. Market Volume, by End User (2017–2030)

20.9. Market Revenue, by End User (2017–2030)

Chapter 21. India Market

21.1. Overview

21.2. Market Volume, by Offering (2017–2030)

21.2.1. Instruments market volume, by type (2017–2030)

21.3. Market Revenue, by Offering (2017–2030)

21.3.1. Instruments market revenue, by type (2017–2030)

21.4. Market Volume, by Allergen (2017–2030)

21.5. Market Revenue, by Allergen (2017–2030)

21.6. Market Volume, by Test Type (2017–2030)

21.7. Market Revenue, by Test Type (2017–2030)

21.8. Market Volume, by End User (2017–2030)

21.9. Market Revenue, by End User (2017–2030)

Chapter 22. Australia Market

22.1. Overview

22.2. Market Volume, by Offering (2017–2030)

22.2.1. Instruments market volume, by type (2017–2030)

22.3. Market Revenue, by Offering (2017–2030)

22.3.1. Instruments market revenue, by type (2017–2030)

22.4. Market Volume, by Allergen (2017–2030)

22.5. Market Revenue, by Allergen (2017–2030)

22.6. Market Volume, by Test Type (2017–2030)

22.7. Market Revenue, by Test Type (2017–2030)

22.8. Market Volume, by End User (2017–2030)

22.9. Market Revenue, by End User (2017–2030)

Chapter 23. South Korea Market

23.1. Overview

23.2. Market Volume, by Offering (2017–2030)

23.2.1. Instruments market volume, by type (2017–2030)

23.3. Market Revenue, by Offering (2017–2030)

23.3.1. Instruments market revenue, by type (2017–2030)

23.4. Market Volume, by Allergen (2017–2030)

23.5. Market Revenue, by Allergen (2017–2030)

23.6. Market Volume, by Test Type (2017–2030)

23.7. Market Revenue, by Test Type (2017–2030)

23.8. Market Volume, by End User (2017–2030)

23.9. Market Revenue, by End User (2017–2030)

Chapter 24. Brazil Market

24.1. Overview

24.2. Market Volume, by Offering (2017–2030)

24.2.1. Instruments market volume, by type (2017–2030)

24.3. Market Revenue, by Offering (2017–2030)

24.3.1. Instruments market revenue, by type (2017–2030)

24.4. Market Volume, by Allergen (2017–2030)

24.5. Market Revenue, by Allergen (2017–2030)

24.6. Market Volume, by Test Type (2017–2030)

24.7. Market Revenue, by Test Type (2017–2030)

24.8. Market Volume, by End User (2017–2030)

24.9. Market Revenue, by End User (2017–2030)

Chapter 25. Mexico Market

25.1. Overview

25.2. Market Volume, by Offering (2017–2030)

25.2.1. Instruments market volume, by type (2017–2030)

25.3. Market Revenue, by Offering (2017–2030)

25.3.1. Instruments market revenue, by type (2017–2030)

25.4. Market Volume, by Allergen (2017–2030)

25.5. Market Revenue, by Allergen (2017–2030)

25.6. Market Volume, by Test Type (2017–2030)

25.7. Market Revenue, by Test Type (2017–2030)

25.8. Market Volume, by End User (2017–2030)

25.9. Market Revenue, by End User (2017–2030)

Chapter 26. Saudi Arabia Market

26.1. Overview

26.2. Market Volume, by Offering (2017–2030)

26.2.1. Instruments market volume, by type (2017–2030)

26.3. Market Revenue, by Offering (2017–2030)

26.3.1. Instruments market revenue, by type (2017–2030)

26.4. Market Volume, by Allergen (2017–2030)

26.5. Market Revenue, by Allergen (2017–2030)

26.6. Market Volume, by Test Type (2017–2030)

26.7. Market Revenue, by Test Type (2017–2030)

26.8. Market Volume, by End User (2017–2030)

26.9. Market Revenue, by End User (2017–2030)

Chapter 27. South Africa Market

27.1. Overview

27.2. Market Volume, by Offering (2017–2030)

27.2.1. Instruments market volume, by type (2017–2030)

27.3. Market Revenue, by Offering (2017–2030)

27.3.1. Instruments market revenue, by type (2017–2030)

27.4. Market Volume, by Allergen (2017–2030)

27.5. Market Revenue, by Allergen (2017–2030)

27.6. Market Volume, by Test Type (2017–2030)

27.7. Market Revenue, by Test Type (2017–2030)

27.8. Market Volume, by End User (2017–2030)

27.9. Market Revenue, by End User (2017–2030)

Chapter 28. U.A.E. Market

28.1. Overview

28.2. Market Volume, by Offering (2017–2030)

28.2.1. Instruments market volume, by type (2017–2030)

28.3. Market Revenue, by Offering (2017–2030)

28.3.1. Instruments market revenue, by type (2017–2030)

28.4. Market Volume, by Allergen (2017–2030)

28.5. Market Revenue, by Allergen (2017–2030)

28.6. Market Volume, by Test Type (2017–2030)

28.7. Market Revenue, by Test Type (2017–2030)

28.8. Market Volume, by End User (2017–2030)

28.9. Market Revenue, by End User (2017–2030)

Chapter 29. Competitive Landscape

29.1. List of Market Players and their Offerings

29.2. Competitive Benchmarking of Key Players

29.3. Product Benchmarking of Key Players

29.4. Recent Strategic Developments

Chapter 30. Company Profiles

30.1. bioMerieux S.A.

30.1.1. Business overview

30.1.2. Product and service offerings

30.1.3. Key financial summary

30.2. Danaher Corporation

30.2.1. Business overview

30.2.2. Product and service offerings

30.2.3. Key financial summary

30.3. Romer Labs Division Holding GmbH

30.3.1. Business overview

30.3.2. Product and service offerings

30.3.3. Key financial summary

30.4. HOB Biotech Group Corp Ltd.

30.4.1. Business overview

30.4.2. Product and service offerings

30.4.3. Key financial summary

30.5. HYCOR Biomedical LLC

30.5.1. Business overview

30.5.2. Product and service offerings

30.5.3. Key financial summary

30.6. NEOGEN Corporation

30.6.1. Business overview

30.6.2. Product and service offerings

30.6.3. Key financial summary

30.7. Eurofins Scientific

30.7.1. Business overview

30.7.2. Product and service offerings

30.7.3. Key financial summary

30.8. Siemens Healthcare GmbH

30.8.1. Business overview

30.8.2. Product and service offerings

30.8.3. Key financial summary

30.9. Stallergenes Greer International AG

30.9.1. Business overview

30.9.2. Product and service offerings

30.9.3. Key financial summary

30.10. Thermo Fisher Scientific

30.10.1. Business overview

30.10.2. Product and service offerings

30.10.3. Key financial summary

Chapter 31. Appendix

31.1. Abbreviations

31.2. Sources and References

31.3. Related Reports

※参考情報 アレルギー診断は、アレルギー反応を引き起こす物質を特定するための手法やプロセスを指します。アレルギーは、免疫系が特定の物質に過剰に反応することによって引き起こされる疾患で、これには花粉、食物、動物の毛、そしてさまざまな化学物質などが含まれます。アレルギー診断は、これらのアレルゲンへの感受性を明らかにするために重要です。 アレルギー診断の主な種類には、皮膚テスト、血清検査、経口負荷試験などがあります。 皮膚テストは、アレルゲンを皮膚に少量接触させる方法です。代表的なものに皮膚プリックテストや皮内テストがあります。皮膚プリックテストでは、アレルゲンを含む液体を皮膚に垂らし、針で軽く刺すことで、アレルギー反応をチェックします。このテストは迅速で、結果も数分で得られるため、診断の際によく利用されます。 血清検査は、血液中の特定の抗体、特にIgE抗体の量を測定する方法です。この検査は、アレルゲンへの曝露があった場合に体内で生成されるIgE抗体を検出します。これにより、さまざまなアレルゲンに対する感受性が評価できるため、より広範なアレルギー診断として利用されます。 経口負荷試験は、特定の食物アレルギーが疑われる患者に対して行われるテストで、医療機関の監視下で少量ずつ食物を摂取させ、アレルギー反応が発生するかどうかを確認します。このテストは比較的リスクを伴うため、必ず医師の指導のもとで行う必要があります。 アレルギー診断の用途は幅広く、診断の精度を向上させ、適切な治療法を選定するために役立ちます。アレルギー性鼻炎や喘息、食物アレルギーなど、さまざまなアレルギーの症状を持つ患者に対して、それぞれの原因を特定することで、生活の質を向上させることができます。また、正確な診断が行われることで、患者が避けるべきアレルゲンを明確にし、突発的なアレルギー反応を未然に防ぐことが可能になります。 関連技術としては、マイクロアレイ技術や遺伝子診断があり、これらは複雑なアレルギー反応を理解するための新しいアプローチとして期待されています。マイクロアレイ技術は、一度に多様なアレルゲンに対する反応を調査できるため、従来の方法に比べて効率的です。また、遺伝子診断は、アレルギー体質を持つ人の遺伝子の変異を調べることで、将来的にアレルギーを予測する手法として注目されています。 アレルギー診断において重要なポイントは、正しい診断を受けるために専門の医師による評価が必要であるということです。自己判断でアレルギーを疑うのではなく、医療機関での専門的なアプローチが求められます。特に、アナフィラキシーのような重篤なアレルギー反応がある場合は、迅速な診断と治療が生死を分けることもあります。 このように、アレルギー診断は多様な手法と技術を駆使して行われ、患者の個別の症状に応じた適切な治療法を見つける上で不可欠なプロセスです。アレルギーを抱える人々がより良い生活を送るためには、精度の高い診断と診療が求められます。アレルギーに対する理解が進むことで、患者自身も自分の体調に対する理解を深め、より効果的な自己管理が可能になるでしょう。アレルギーの研究は進展中であり、新たな診断技術や治療法の開発が期待されています。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer